Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
Next revision Both sides next revision
orcs:featured_screens [2020/04/18 21:48]
biogridadmin
orcs:featured_screens [2020/08/18 14:40]
biogridadmin
Line 5: Line 5:
  
 ==== 2020 Datasets ==== ==== 2020 Datasets ====
 +  * **[[https://​orcs.thebiogrid.org/​Dataset/​268|Dhoonmoon A et al.]]** - **Genome-wide CRISPR synthetic lethality screen identifies a role for the ADP-ribosyltransferase PARP14 in DNA replication dynamics controlled by ATR.** Nucleic Acids Research. July, 2020.
   * **[[https://​orcs.thebiogrid.org/​Dataset/​258|Labeau A et al.]]** - **A Genome-Wide CRISPR-Cas9 Screen Identifies the Dolichol-Phosphate Mannose Synthase Complex as a Host Dependency Factor for Dengue Virus Infection.** Journal of virology. March, 2020.   * **[[https://​orcs.thebiogrid.org/​Dataset/​258|Labeau A et al.]]** - **A Genome-Wide CRISPR-Cas9 Screen Identifies the Dolichol-Phosphate Mannose Synthase Complex as a Host Dependency Factor for Dengue Virus Infection.** Journal of virology. March, 2020.
  
Line 10: Line 11:
   * **[[https://​orcs.thebiogrid.org/​Dataset/​210|Zhuang X et al.]]** - **Genome-Wide CRISPR Screen Reveals Cancer Cell Resistance to NK Cells Induced by NK-Derived IFN-γ.** Frontiers in immunology. January, 2019.   * **[[https://​orcs.thebiogrid.org/​Dataset/​210|Zhuang X et al.]]** - **Genome-Wide CRISPR Screen Reveals Cancer Cell Resistance to NK Cells Induced by NK-Derived IFN-γ.** Frontiers in immunology. January, 2019.
   * **[[https://​orcs.thebiogrid.org/​Dataset/​114|Behan FM et al.]]** - **Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.** Nature. April 10, 2019.   * **[[https://​orcs.thebiogrid.org/​Dataset/​114|Behan FM et al.]]** - **Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.** Nature. April 10, 2019.
 +  * **[[https://​orcs.thebiogrid.org/​Dataset/​152|MacLeod G et al.]]** - **Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.** Cell Reports. April 16, 2019
  
 ==== 2018 Datasets ==== ==== 2018 Datasets ====
Line 16: Line 18:
  
 ==== 2017 Datasets ==== ==== 2017 Datasets ====
-  * **[[https://​orcs.thebiogrid.org/​Dataset/​41|Meyers RM et al.]]** - **Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.** Nature Genetics. December 1, 2017. 
   * **[[https://​orcs.thebiogrid.org/​Dataset/​22|Bertomeu T et al.]]** - **A high resolution genome-wide CRISPR/Cas9 viability screen reveals structural features and contextual diversity of the human cell-essential proteome.** Molecular and Cellular Biology. October 16, 2017.   * **[[https://​orcs.thebiogrid.org/​Dataset/​22|Bertomeu T et al.]]** - **A high resolution genome-wide CRISPR/Cas9 viability screen reveals structural features and contextual diversity of the human cell-essential proteome.** Molecular and Cellular Biology. October 16, 2017.
 +  * **[[https://​orcs.thebiogrid.org/​Dataset/​41|Meyers RM et al.]]** - **Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.** Nature Genetics. December 1, 2017.
 +
 
orcs/featured_screens.txt · Last modified: 2023/11/20 11:34 by biogridadmin